Evidence map›Paper›PMID 29896160›Full record

ArticleFrontiers in microbiology2018

The Probiotic

Susanne Bury, Manonmani Soundararajan, Richa Bharti, Rudolf von Bünau, Konrad U Förstner, Tobias A Oelschlaeger

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Enhancing the antibacterial function of probioticApplied and environmental microbiology · 2023
    Article
  3. Article
  4. Rational design of a genome-based insulated system inBioengineering & translational medicine · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Susanne BuryInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Manonmani SoundararajanInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Richa BhartiInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Rudolf von BünauArdeypharm GmbH, Herdecke, Germany.
Konrad U FörstnerInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Tobias A OelschlaegerInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
University of Würzburg · DEArdeypharm (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin (Stx) producing

Indexed as

E. coli Nissle 1917EHECLamBlambda-phageslambdoid prophageprobioticShiga toxin producing E. colistx-phages

Identifiers

PMID29896160
PMCPMC5987069
OpenAlexW2807130658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.